Kaltenbach G, Andrès E, Barnier-Figue G, Noblet-Dick M, Noël E, Vogel T, Perrin A E, Berthel M
Centre de gérontologie, Hôpital de la Robertsau, Strasbourg.
Presse Med. 2005 Mar 12;34(5):358-62.
Non-dissociation of vitamin B12 from its carrying proteins is the most frequent cause of vitamin B12 deficiency in the elderly. The aim of this study was to determine the initial dose of oral cyanocobalamin that would correct the B12 vitamin deficiency within one week.
This was an open, prospective, study on 30 elderly patients suffering from vitamin deficiency (B12 < 0.20 microg/L) induced by food-cobalamin malabsorption. Ten patients (group I) were treated with a daily dose of 1000 microg of oral cyanocobalamin (from D1 to D8), 10 (group II) with 1000 microg every other day (D1, D3, D5 and D7), 5 (group III) with 1000 microg every 4 days (D1 and D5) and 5 (group IV) with 1000 microg only on D1. The biological response was assessed by control measurement of vitamin B12 serum levels on the 8th day.
Mean vitamin B12 serum levels had significantly increased (p < 0.01) in groups I, II and III, but not in group IV. The dose-effect, assessed by the mean increase in vitamin B12 serum levels, was significantly greater (p < 0.05) in groups I (0.25 microg/L) and II (0.18 microg/L), than in groups III and IV (0.09 microg/L).
This prospective study shows that an oral dose of 1000 microg of cyanocobalamin every 4 days, which corresponds to 250 microg per day, was sufficient to correct B12 vitamin deficiency induced by food-cobalamin malabsorption within one week. However, initial doses of 1000 microg per day or every other day would be preferable because of the greater dose-effect with daily doses higher than 500 microg. A randomised study is warranted to validate these preliminary results.
维生素B12与其运载蛋白不分离是老年人维生素B12缺乏最常见的原因。本研究的目的是确定能在一周内纠正维生素B12缺乏的口服氰钴胺初始剂量。
这是一项针对30例因食物钴胺素吸收不良导致维生素缺乏(维生素B12<0.20μg/L)的老年患者的开放性前瞻性研究。10例患者(I组)每天口服1000μg氰钴胺(从第1天至第8天),10例(II组)每隔一天口服1000μg(第1、3、5和7天),5例(III组)每4天口服1000μg(第1和5天),5例(IV组)仅在第1天口服1000μg。通过在第8天对照测量维生素B12血清水平来评估生物学反应。
I、II和III组的维生素B12血清平均水平显著升高(p<0.01),而IV组未升高。通过维生素B12血清水平的平均升高评估的剂量效应,I组(0.25μg/L)和II组(0.18μg/L)显著大于III组和IV组(0.09μg/L)(p<0.05)。
这项前瞻性研究表明,每4天口服1000μg氰钴胺,相当于每天250μg,足以在一周内纠正食物钴胺素吸收不良引起的维生素B12缺乏。然而,由于每日剂量高于500μg时剂量效应更大,每天或每隔一天1000μg的初始剂量可能更可取。有必要进行一项随机研究来验证这些初步结果。